SRA's number for the day: 25
This article was originally published in SRA
Executive Summary
Between 1 October 2012 and 26 July 2013, the Food and Drug Administration approved 25 of the 73 applications it received from drug companies requesting that the agency review their investigational drug under the breakthrough therapy designation pathway.